Understanding PACS Data in Population Health

Picture Archiving and Communication Systems (PACS) serve as the digital backbone for storing, retrieving, and sharing medical images such as X-rays, MRIs, CT scans, and ultrasounds. These systems are now foundational to modern radiology and hold immense potential for population health research. By aggregating imaging data across large patient populations, researchers can uncover patterns in disease prevalence, progression, and treatment response that are invisible in smaller, single‑institution datasets. The volume of imaging data is growing rapidly — in 2023, more than 3.6 billion imaging procedures were performed globally, according to the OECD. This wealth of visual information, combined with rich metadata (patient demographics, acquisition parameters, clinical indications), transforms PACS into a powerful epidemiological resource.

Types of Imaging Data Captured

PACS repositories contain diverse modalities. Plain radiography (chest X‑rays, skeletal films) remains the most common, but CT, MRI, ultrasound, nuclear medicine, and mammography studies are equally important. Each modality captures different tissue properties and pathophysiological processes. For example, chest CT densitometry can quantify emphysema severity; MRI diffusion sequences reveal microstructural changes in neurodegenerative diseases. The ability to pool these data across institutions and time periods enables longitudinal studies that track disease evolution and the impact of public health interventions.

Metadata: The Hidden Goldmine

Beyond the pixel data, PACS stores structured metadata in DICOM tags: patient age, sex, study description, body part examined, scanner type, and often, follow‑up intervals. This metadata is invaluable for stratifying populations. A researcher can extract all chest CTs performed in a given geographic region over five years, filter by patient age and sex, and examine trends in lung nodule detection rates. When linked to electronic health records (EHRs), these metadata become the backbone of comprehensive population health analyses.

The Role of PACS in Shifting from Individual to Population Health

Traditionally, radiology focused on the individual patient: diagnosing disease, guiding treatment, and monitoring outcomes. PACS data enables a paradigm shift from individual‑centric reporting to population‑level insights. For instance, mammography registries that use PACS data to track screening adherence and cancer detection rates have led to evidence‑based changes in screening guidelines worldwide. Similarly, analyzing CT calcium scoring trends across primary care populations helps identify regions with higher cardiovascular disease risk, directing preventive resources more effectively.

Large health systems like the Veterans Health Administration have leveraged PACS data to monitor the prevalence of chronic diseases such as COPD and diabetes‑related complications across veteran populations. These datasets also power the Radiology Society of North America’s research initiatives, where de‑identified imaging cohorts are shared for multi‑institutional studies. The shift is not just academic — payers and public health agencies increasingly demand imaging‑based metrics to assess population health outcomes.

Steps to Utilize PACS Data Effectively

Extracting actionable population health insights from PACS requires a systematic approach that respects data privacy, ensures scientific validity, and leverages modern analytics tools. Below are the critical phases.

Data Extraction

Secure extraction is the first step. Collaborate with your healthcare organization’s IT and informatics teams to export imaging studies via DICOM‑compliant protocols. Use query‑retrieve or DICOM‑web APIs to pull only the studies relevant to your research question. For example, to study hip fracture patterns in elderly women, extract pelvis and hip X‑rays or CTs using billing codes or radiology report keywords. Limit the extraction to the required time window and patient demographics to reduce downstream processing. Always ensure that extraction procedures comply with institutional data governance policies.

Data Anonymization

Before analysis, de‑identify all images and metadata. Remove DICOM tags containing protected health information (PHI) such as patient name, MRN, and date of birth. Advanced tools like NVIDIA Clara DeIdentify or the RSNA‑funded DICOM De‑identification Guidelines can automate much of this process. For longitudinal studies, a token‑based pseudonymization approach (maintaining a secure mapping to original identifiers outside the research dataset) may be needed to link imaging data across time while preserving privacy. Validate de‑identification by scanning the output for residual PHI.

Data Integration

PACS data alone tells only part of the story. For population health research, combine imaging data with EHRs, lab results, pharmacy records, and demographic databases. A common strategy is to use a secure research data warehouse where structured data (from EHRs) and unstructured data (from radiology reports and image features) are harmonized. Integration enables powerful analyses: for example, linking chest CT findings (e.g., coronary artery calcification) with lipid profiles and cardiovascular events to compute risk scores at the population level. Use standardized terminologies like SNOMED CT and LOINC to facilitate cross‑database matching. Tools such as the Observational Medical Outcomes Partnership (OMOP) Common Data Model are increasingly adopted for this purpose.

Analysis

Image analysis ranges from simple feature extraction (e.g., lung nodule diameter, bone density measurements) to advanced deep‑learning‑based phenotyping. For epidemiological studies, automated pipelines that quantify disease markers (e.g., emphysema severity, liver fat fraction, brain atrophy) enable high‑throughput, reproducible measurements across thousands of scans. Platforms like MGH Biobank use such pipelines. Statistical analysis should account for clustering within institutions and repeated measures; mixed‑effects models and survival analysis are common. Machine learning models, when carefully validated, can identify novel imaging biomarkers — for instance, predicting future cardiovascular events from routine chest CT scans.

Interpretation

Collaborate closely with clinicians and epidemiologists to translate imaging findings into population health implications. Imaging patterns may correlate with environmental exposures (e.g., higher lung fibrosis rates near industrial zones), socioeconomic factors (e.g., lower mammography adherence in underserved areas), or health policy changes (e.g., increase in early‑stage lung cancer detection after implementing low‑dose CT screening). Use visualization tools — heatmaps, geographic information systems (GIS) overlays — to communicate trends to public health stakeholders. The ultimate goal is to produce actionable intelligence: which subpopulations need targeted screening, which interventions show measurable impact on disease burden.

Applications in Epidemiology

PACS data has already proven its value across multiple epidemiological domains. Below are key application areas with real‑world examples.

Disease Surveillance and Outbreak Detection

During the COVID‑19 pandemic, PACS data from chest X‑rays and CT scans enabled near‑real‑time monitoring of infection burden, geographic spread, and severity. Researchers constructed automated pipelines to extract “COVID‑19‑positive” labels from radiology reports and correlated them with hospitalization rates and mortality. Similar approaches are now being applied to seasonal influenza, respiratory syncytial virus (RSV), and emerging pathogens. The ability to retrospectively analyze pre‑pandemic imaging datasets also helps define baseline radiological patterns, improving detection of novel disease signatures.

Chronic Disease Epidemiology

Imaging biomarkers are essential for tracking chronic diseases. PACS data on bone mineral density from dual‑energy X‑ray absorptiometry (DXA) scans is used to map osteoporosis prevalence and fracture risk across populations. Coronary artery calcium scoring from CT scans is aggregated to create regional cardiovascular disease risk maps. These data inform public health campaigns — for example, targeting vitamin D supplementation in areas with high osteoporosis prevalence. Longitudinal imaging (e.g., serial brain MRIs in aging populations) helps epidemiologists understand the natural history of dementia and the impact of modifiable risk factors.

Environmental and Occupational Health

Population‑level imaging data can reveal links between environmental exposures and disease. Studies have used PACS data to correlate regional air pollution levels with lung cancer incidence (from chest CT screens) or with childhood asthma exacerbations (from emergency department chest X‑rays). In occupational health, retired miners’ X‑rays archived in PACS have been analyzed to identify patterns of pneumoconiosis, leading to stricter workplace safety regulations. When combined with geographic and temporal data, PACS becomes a powerful tool for environmental epidemiology.

Health Disparities Research

PACS data can expose inequalities in healthcare access and outcomes. For instance, researchers can compare the stage at which breast cancer is detected (assessed from mammography) between different ethnic or socioeconomic groups. They can also examine differences in the utilization of advanced imaging (e.g., CT, MRI) for stroke diagnosis across hospital types. Findings from such studies help target resources to underserved communities and monitor the effectiveness of equity initiatives. The Agency for Healthcare Research and Quality supports several projects that leverage PACS data for disparities research.

Challenges and Considerations

While the potential of PACS data is vast, researchers must navigate significant challenges.

Data Privacy and Governance

Medical images contain more than pixel data; they can inadvertently reveal identifiable features (e.g., facial contours in CT head scans, implanted device serial numbers). Strict de‑identification protocols and governance frameworks are essential. Organizations must establish data use agreements, obtain IRB approval (or exemption for de‑identified data), and ensure compliance with HIPAA, GDPR, and local regulations. A breach involving imaging data can be particularly damaging given the sensitivity of visual information. Researchers should also consider using trusted research environments (secure enclaves) where data never leaves the institution.

Data Standardization and Interoperability

Variability in imaging protocols across facilities — different scanner manufacturers, acquisition parameters, reconstruction algorithms — can introduce systematic biases. For example, CT lung nodule measurements may vary depending on slice thickness and reconstruction kernel. Without careful harmonization, these differences can confound epidemiological analyses. Imaging biobanks like the UK Biobank have invested heavily in standardized protocols. For retrospective studies, statistical calibration (e.g., ComBat harmonization) can reduce site‑level variation. Yet, interoperability between PACS from different vendors remains a challenge; adoption of standards like FHIR for imaging reports and DICOM for image exchange is improving but not universal.

Technical Resources and Infrastructure

Analyzing large imaging datasets requires significant computational power, storage, and specialized software. A single high‑resolution CT study can be 500 MB or more. Researchers need access to high‑performance computing clusters or cloud platforms (e.g., Google Cloud Healthcare API) and tools for image processing (e.g., 3D Slicer, MONAI, DeepLesion). Smaller institutions may lack these resources, exacerbating disparities in who can conduct PACS‑based population health research. Collaborative networks and shared analysis platforms (e.g., the RSNA AI Foundation) can help democratize access.

Bias and Generalizability

Imaging datasets are often derived from specific hospital populations, which may not represent the broader community. For instance, a PACS dataset from a tertiary‑care center will contain a higher proportion of complex cases than community hospitals. If used to train predictive models or estimate population prevalence, results may be biased. Researchers should assess the generalizability of their findings and consider weighting techniques or multi‑site validation. Additionally, historical PACS data may reflect past screening practices (e.g., fewer lung cancer screenings in 2010 vs. today), requiring careful interpretation of temporal trends.

Future Directions

The next decade promises transformative advances in PACS‑based population health research. Artificial intelligence (AI) will automate image phenotyping at unprecedented scale, enabling real‑time population surveillance — for example, flagging unusual clusters of imaging findings that suggest a new disease outbreak. Federated learning will allow institutions to train models across multiple PACS repositories without sharing raw data, preserving privacy while improving model robustness. Integration with genomic data (radiogenomics) will help link imaging phenotypes to underlying biological pathways, opening new avenues for precision public health. Finally, as PACS become more interoperable with health information exchanges, researchers will gain access to longitudinal imaging histories across entire regions, enabling studies on the lifetime impact of environmental exposures, chronic diseases, and healthcare policies.

Conclusion

PACS data is a powerful but underutilized resource for population health and epidemiology. By systematically extracting, anonymizing, integrating, and analyzing imaging data, researchers can uncover disease patterns, monitor public health interventions, and reduce health disparities. Challenges around privacy, standardization, and technical access remain, but collaborative efforts and technological advancements are steadily lowering barriers. For institutions already invested in PACS, the opportunity to contribute to population health research is immense. By treating imaging data as a strategic asset — not just a clinical archive — healthcare organizations can play a pivotal role in improving health outcomes for entire communities.